A COVID-19 pandemic guideline in evidence-based medicine
Reviews
[키워드] 24 hour
acute respiratory syndrome
administration
Admission
albumin
approach
articles
Baricitinib
Blood
Chinese
Chloroquine
claimed
clinical guideline
clinical study
complications of COVID-19
concerning
conducted
coronavirus
coronavirus disease
Corticosteroids
Course
COVID-19
COVID-19 complications
COVID-19 pandemic
COVID-19 patients
Critical
Diagnosis
discharge
disease
drug
Endotracheal intubation
English
epidemiological
Evidence
Evolution
exclusion criteria
extracorporeal membrane oxygenation
Factor
Features
groups
help
high risk
home quarantine
hospitalisation
In-vitro
information
intensive care
Intervention
intravenous
introduced
Invasive mechanical ventilation
laboratory result
management
management guideline
Measures
mild infection
Neonatal
Neonates
observational studies
oseltamivir
Oxygen therapy
Patient
patients with COVID-19
positive airway pressure
protein level
reduce
Remdesivir
reported
Reproduction number
required
response
Result
ruxolitinib
SARS-CoV-2
sequence
social distancing
social isolation
Spread
spread of COVID-19
suggested
symptomatic
Symptoms
the SARS-CoV-2
therapy
Transmission
Treatment
treatment guidelines
Trial
trials
vasopressors
viral clearance
vital sign
[DOI] 10.1038/s41432-020-0105-7 [Article Type] Reviews
[DOI] 10.1038/s41432-020-0105-7 [Article Type] Reviews